ProShare Advisors LLC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 129 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$103,676
-21.9%
16,327
-25.5%
0.00%
Q1 2024$132,726
+8.4%
21,902
+8.6%
0.00%
Q4 2023$122,468
+83.3%
20,176
+27.4%
0.00%
Q3 2023$66,824
+36.0%
15,835
-0.1%
0.00%
Q2 2023$49,148
+191.7%
15,854
+30.8%
0.00%
Q1 2023$16,848
-36.1%
12,121
-8.5%
0.00%
Q4 2022$26,373
+14.7%
13,253
+16.7%
0.00%
Q3 2022$23,000
-37.8%
11,353
-1.9%
0.00%
Q2 2022$37,000
-52.6%
11,569
-38.2%
0.00%
Q1 2022$78,000
-25.7%
18,706
-14.1%
0.00%
Q4 2021$105,000
+54.4%
21,782
+70.5%
0.00%
Q3 2021$68,000
-48.5%
12,776
-50.6%
0.00%
Q2 2021$132,000
-26.3%
25,870
-2.5%
0.00%
-100.0%
Q1 2021$179,000
+79.0%
26,524
+20.7%
0.00%
Q4 2020$100,000
+112.8%
21,972
+80.8%
0.00%
Q3 2020$47,000
-26.6%
12,156
-9.8%
0.00%
Q2 2020$64,000
-16.9%
13,480
-15.9%
0.00%
Q4 2019$77,000
+148.4%
16,027
+50.1%
0.00%
Q3 2019$31,000
-61.2%
10,674
-4.3%
0.00%
Q2 2019$80,000
-55.3%
11,154
-11.7%
0.00%
-100.0%
Q1 2019$179,000
+15.5%
12,638
+10.1%
0.00%0.0%
Q4 2018$155,000
-47.3%
11,477
-13.5%
0.00%
-50.0%
Q3 2018$294,000
+35.5%
13,267
+0.3%
0.00%
+100.0%
Q2 2018$217,00013,2280.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Fosun International Ltd 19,552,001$433,859,00020.80%
BRIDGER MANAGEMENT, LLC 2,642,621$58,640,0003.39%
TPG Group Holdings (SBS) Advisors, Inc. 3,884,600$86,199,0001.10%
HUSSMAN STRATEGIC ADVISORS, INC. 125,000$2,774,0000.80%
HealthCor Management, L.P. 1,036,110$22,991,0000.76%
GW&K Investment Management, LLC 2,049,765$45,484,0000.73%
Bridge City Capital, LLC 50,434$1,119,0000.70%
TCW GROUP INC 2,521,064$55,942,0000.46%
FRONTIER CAPITAL MANAGEMENT CO LLC 2,876,367$63,827,0000.41%
Quadrant Capital Management, LLC 25,002$555,0000.35%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders